TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Investor Securities Class Action Lawsuit 08/03/2023

  • If you purchased a significant amount of shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021, and July 28, 2023, and / or if you purchased any NASDAQ: APLS shares prior to January 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 2, 2023. NASDAQ: APLS investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 8, 2024 - An amended complaint was filed. August 03, 2023  - An investor in shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) filed a lawsuit in the U.S. District Court for the District of Delaware over alleged violations of Federal Securities Laws by Apellis Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between January 2...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)